|
1
|
Harvey RC, Mullighan CG, Wang X, Dobbin
KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, et
al: Identification of novel cluster groups in pediatric high-risk
B-precursor acute lymphoblastic leukemia with gene expression
profiling: Correlation with genome-wide DNA copy number
alterations, clinical characteristics, and outcome. Blood.
116:4874–4884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bailey LC, Lange BJ, Rheingold SR and
Bunin NJ: Bone-marrow relapse in paediatric acute lymphoblastic
leukaemia. Lancet Oncol. 9:873–883. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moorman AV, Ensor HM, Richards SM, Chilton
L, Schwab C, Kinsey SE, Vora A, Mitchell CD and Harrison CJ:
Prognostic effect of chromosomal abnormalities in childhood B-cell
precursor acute lymphoblastic leukaemia: Results from the UK
Medical Research Council ALL97/99 randomised trial. Lancet Oncol.
11:429–438. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moorman AV: The clinical relevance of
chromosomal and genomic abnormalities in B-cell precursor acute
lymphoblastic leukaemia. Blood Rev. 26:123–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oikawa T: ETS transcription factors:
possible targets for cancer therapy. Cancer Sci. 95:626–633. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anderson MK, Hernandez-Hoyos G, Diamond RA
and Rothenberg EV: Precise developmental regulation of Ets family
transcription factors during specification and commitment to the T
cell lineage. Development. 126:3131–3148. 1999.PubMed/NCBI
|
|
7
|
Hart AH, Corrick CM, Tymms MJ, Hertzog PJ
and Kola I: Human ERG is a proto-oncogene with mitogenic and
transforming activity. Oncogene. 10:1423–1430. 1995.PubMed/NCBI
|
|
8
|
Sorensen PH, Lessnick SL, Lopez-Terrada D,
Liu XF, Triche TJ and Denny CT: A second Ewing's sarcoma
translocation, t(21;22), fuses the EWS gene to another ETS-family
transcription factor, ERG. Nat Genet. 6:146–151. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tomlins SA, Rhodes DR, Perner S,
Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J,
Kuefer R, et al: Recurrent fusion of TMPRSS2 and ETS transcription
factor genes in prostate cancer. Science. 310:644–648. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marcucci G, Baldus CD, Ruppert AS,
Radmacher MD, Mrózek K, Whitman SP, Kolitz JE, Edwards CG, Vardiman
JW, Powell BL, et al: Overexpression of the ETS-related gene, ERG,
predicts a worse outcome in acute myeloid leukemia with normal
karyotype: A Cancer and Leukemia Group B study. J Clin Oncol.
23:9234–9242. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marcucci G, Maharry K, Whitman SP,
Vukosavljevic T, Paschka P, Langer C, Mrózek K, Baldus CD, Carroll
AJ, Powell BL, et al: High expression levels of the ETS-related
gene, ERG, predict adverse outcome and improve molecular risk-based
classification of cytogenetically normal acute myeloid leukemia: A
Cancer and Leukemia Group B Study. J Clin Oncol. 25:3337–3343.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eid MA, Attia M, Abdou S, El-Shazly SF,
Elahwal L, Farrag W and Mahmoud L: BAALC and ERG expression in
acute myeloid leukemia with normal karyotype: Impact on prognosis.
Int J Lab Hematol. 32:197–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Metzeler KH, Dufour A, Benthaus T, Hummel
M, Sauerland MC, Heinecke A, Berdel WE, Büchner T, Wörmann B,
Mansmann U, et al: ERG expression is an independent prognostic
factor and allows refined risk stratification in cytogenetically
normal acute myeloid leukemia: A comprehensive analysis of ERG,
MN1, and BAALC transcript levels using oligonucleotide microarrays.
J Clin Oncol. 27:5031–5038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schwind S, Marcucci G, Maharry K,
Radmacher MD, Mrózek K, Holland KB, Margeson D, Becker H, Whitman
SP, Wu YZ, et al: BAALC and ERG expression levels are associated
with outcome and distinct gene and microRNA expression profiles in
older patients with de novo cytogenetically normal acute myeloid
leukemia: A Cancer and Leukemia Group B study. Blood.
116:5660–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baldus CD, Burmeister T, Martus P,
Schwartz S, Gökbuget N, Bloomfield CD, Hoelzer D, Thiel E and
Hofmann WK: High expression of the ETS transcription factor ERG
predicts adverse outcome in acute T-lymphoblastic leukemia in
adults. J Clin Oncol. 24:4714–4720. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baldus CD, Martus P, Burmeister T,
Schwartz S, Gökbuget N, Bloomfield CD, Hoelzer D, Thiel E and
Hofmann WK: Low ERG and BAALC expression identifies a new subgroup
of adult acute T-lymphoblastic leukemia with a highly favorable
outcome. J Clin Oncol. 25:3739–3745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pigazzi M, Masetti R, Martinolli F, Manara
E, Beghin A, Rondelli R, Locatelli F, Fagioli F, Pession A and
Basso G: Presence of high-ERG expression is an independent
unfavorable prognostic marker in MLL-rearranged childhood myeloid
leukemia. Blood. 119:1086–1087; author reply 1087–1088. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hermkens MC, van den Heuvel-Eibrink MM,
Arentsen-Peters ST, Baruchel A, Stary J, Reinhardt D, Zimmerman M,
de Haas V, Pieters R and Zwaan CM: The clinical relevance of BAALC
and ERG expression levels in pediatric AML. Leukemia. 27:735–737.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Subspecialty Group of Hematology Diseases,
The Society of Pediatrics, Chinese Medical Association; Editorial
Board, Chinese Journal of Pediatrics, . Recommendations for
diagnosis and treatment of acute lymphoblastic leukemia in
childhood (3rd revised version). Zhonghua Er Ke Za Zhi. 44:392–395.
2006.(In Chinese). PubMed/NCBI
|
|
20
|
Xu XJ, Tang YM, Shen HQ, Song H, Yang SL,
Shi SW and Xu WQ: Day 22 of induction therapy is important for
minimal residual disease assessment by flow cytometry in childhood
acute lymphoblastic leukemia. Leuk Res. 36:1022–1027. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mu Q, Wang Y, Chen B, Qian W, Meng H, Tong
H, Chen F, Ma Q, Ni W, Chen S and Jin J: High expression of
Musashi-2 indicates poor prognosis in adult B-cell acute
lymphoblastic leukemia. Leuk Res. 37:922–927. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mullighan CG, Miller CB, Radtke I,
Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui
CH, et al: BCR-ABL1 lymphoblastic leukaemia is characterized by the
deletion of Ikaros. Nature. 453:110–114. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oikawa T and Yamada T: Molecular biology
of the Ets family of transcription factors. Gene. 303:11–34. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ichikawa H, Shimizu K, Hayashi Y and Ohki
M: An RNA-binding protein gene, TLS/FUS, is fused to ERG in human
myeloid leukemia with t(16;21) chromosomal translocation. Cancer
Res. 54:2865–2868. 1994.PubMed/NCBI
|
|
25
|
Rainis L, Toki T, Pimanda JE, Rosenthal E,
Machol K, Strehl S, Göttgens B, Ito E and Izraeli S: The
proto-oncogene ERG in megakaryoblastic leukemias. Cancer Res.
65:7596–7602. 2005.PubMed/NCBI
|
|
26
|
Dombret H, Gabert J, Boiron JM,
Rigal-Huguet F, Blaise D, Thomas X, Delannoy A, Buzyn A,
Bilhou-Nabera C, Cayuela JM, et al: Outcome of treatment in adults
with Philadelphia chromosome-positive acute lymphoblastic
leukemia-results of the prospective multicenter LALA-94 trial.
Blood. 100:2357–2366. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gleissner B, Gökbuget N, Bartram CR,
Janssen B, Rieder H, Janssen JW, Fonatsch C, Heyll A, Voliotis D,
Beck J, et al: Leading prognostic relevance of the BCR-ABL
translocation in adult acute B-lineage lymphoblastic leukemia: A
prospective study of the German Multicenter Trial Group and
confirmed polymerase chain reaction analysis. Blood. 99:1536–1543.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mancini M, Scappaticci D, Cimino G, Nanni
M, Derme V, Elia L, Tafuri A, Vignetti M, Vitale A, Cuneo A, et al:
A comprehensive genetic classification of adult acute lymphoblastic
leukemia (ALL): Analysis of the GIMEMA 0496 protocol. Blood.
105:3434–3441. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu P, Lin Z, Qian S, Qiao C, Qiu H, Wu Y,
Li J and Ge Z: Expression of dominant-negative Ikaros isoforms and
associated genetic alterations in Chinese adult patients with
leukemia. Ann Hematol. 91:1039–1049. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Staffas A, Kanduri M, Hovland R,
Rosenquist R, Ommen HB, Abrahamsson J, Forestier E, Jahnukainen K,
Jónsson ÓG, Zeller B, et al: Presence of FLT3-ITD and high BAALC
expression are independent prognostic markers in childhood acute
myeloid leukemia. Blood. 118:5905–5913. 2011. View Article : Google Scholar : PubMed/NCBI
|
